biotech
Phytolon and Ginkgo Bioworks announce natural food colour production milestone
Phytolon and Ginkgo Bioworks have announced the successful completion of the second development milestone in their multi-product collaboration to produce natural food colours.
Report: European alternative protein investment hits $509m, but sector remains immature
In a year marked by significant growth, European alternative protein companies attracted nearly $509 million (€470 million) in investment during 2024, reflecting a 23% increase from the previous year.
UK government invests £1.4m in expanding precision fermentation expertise
The UK has invested £1.4m into a new innovation hub, aiming to enable the Food Standards Agency to broaden its expertise in new food-tech.
Crunchtime podcast: Exploring the impact of the new C-Label and F-Label
We explore the impact of V-Label's new certifications for foods made with advanced cell cultivation and fermentation technologies.
Debut develops animal-free carmine following enzyme discovery milestone
Debut has announced a significant breakthrough in animal-free bioproduction of the traditionally beetle-derived red colourant, carmine.
Äio scales fermentation-based fat and oil production to 10,000 litres
Äio has successfully scaled production of its fermentation-made fats and oils to an industrial-level batch of 10,000 litres.
Standing Ovation and Ajinomoto forge partnership to advance alt-protein production
Standing Ovation, a French biotech company, has announced a partnership with Ajinomoto Foods Europe to advance alt-protein production.
Cradle raises $73m in Series B funding round for AI-powered protein engineering technology
Cradle has raised $73m in Series B funding to address rising demand for its AI-powered protein engineering technology.
Start-up spotlight: NoPalm Ingredients
This time, we speak to NoPalm Ingredients, a Dutch biotechnology company that is on a mission to produce palm oil without palm trees.
LanzaTech expands into producing nutritional protein from CO2
US biotech company LanzaTech has announced plans to expand into the alternative protein market, producing a microbial protein from CO2.
Helaina raises $45m to speed-up commercialisation of human bioactive proteins
US biotech start-up Helaina has raised $45 million in a Series B funding round led by investment firm Avidity Partners.